Millennium Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $940K | Sell |
|
|||||
|
2024
Q1 | $1.35M | Sell |
|
|||||
|
2023
Q4 | $2.73M | Buy |
|
|||||
|
2023
Q3 | $5.48M | Buy |
|
|||||
|
2023
Q2 | $5.48M | Sell |
|
|||||
|
2023
Q1 | $8.44M | Buy |
|
|||||
|
2022
Q4 | $2.62M | Sell |
|
|||||
|
2022
Q3 | $4.35M | Sell |
|
|||||
|
2022
Q2 | $14M | Buy |
|
|||||
|
2022
Q1 | $616K | Sell |
|
|||||
|
2021
Q4 | $654K | Sell |
|
|||||
|
2021
Q3 | $767K | Sell |
|
|||||
|
2021
Q2 | $2.86M | Sell |
|
|||||
|
2021
Q1 | $3.61M | Buy |
|
|||||
|
2020
Q4 | $2.92M | Buy |
|
|||||
|
2020
Q3 | $1.14K | Sell |
|
|||||
|
2020
Q2 | $5.39M | Buy |
|
|||||
|
2020
Q1 | $282K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.64M | Buy |
|
|||||
|
2019
Q2 | $608K | Sell |
|
|||||
|
2019
Q1 | $9.74M | Sell |
|
|||||
|
2018
Q4 | $11.5M | Buy |
|
|||||
|
2018
Q3 | $794K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.11M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $6.8M | Buy |
|
|||||
|
2017
Q1 | $297K | Sell |
|
|||||
|
2016
Q4 | $5.97M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $7.24M | Buy |
|
|||||
|
2016
Q1 | $3.18M | Buy |
|
|||||
|
2015
Q4 | $491K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $902K | Sell |
|
|||||
|
2015
Q1 | $1.44M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $164K | Buy |
|